Who invested in Preceptis Medical

3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$5.9Mraised across 3 rounds since 2011, from 3 sources

$500KDebt$4.4MVenture$976KVenture

Latest round: Venture, $976KJun 2015
Biggest round: $4.4MVenture · Jan 2014
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2012201320142015

$500KDebt$4.4MVenture$976KVenture

First round: Debt, $500K
Biggest round: $4.4M
Usual gap between rounds: 2.2 years

The rounds

Jun 2015
Venture$976K
No investor was named in the report.
From a historical funding recordSEC filing: $976K sold, first sale May 2015
Jan 2014
Venture$4.4M1 new
- Partisan Management Group
From a historical funding recordSEC filing: $4.4M sold, first sale Jan 2014
Dec 2011
Debt$500K
No investor was named in the report.
Reported by sec.govSEC filing: $500K sold, first sale Dec 2011

Founders and team

From Preceptis Medical's own website: 5 on the team.

David CareyChief Executive Officer
Andreas DeibelVice President of R&D and Operations
Greg MielkeChief Commercial Officer
Aaron AizaSales Director
Sam JonesSenior Director of Reimbursement & Market Access

Everyone who backed them

Partisan Management GroupVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Preceptis Medical as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.